SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-033545
Filing Date
2018-06-08
Accepted
2018-06-08 16:07:26
Documents
2
Period of Report
2018-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv496078_3.html 3  
1 OWNERSHIP DOCUMENT tv496078_3.xml 3 6888
2 EXHIBIT 24.1 tv496078_ex24-1.htm EX-24.1 4725
  Complete submission text file 0001144204-18-033545.txt   13218
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address
Naos Yaron (Reporting) CIK: 0001742727 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 18889520